CDK12 and neoplasm: For the two cases of mutation with loss of heterozygosity, although there was no decrease in CDK12 copy numbers in both of them, we judged them to be biallelic loss because only the pathogenic allele was present as the VAF was almost equal to the tumor content (Fig. 1).